REGENXBIO, Inc. (RGNX)
5.72
-0.52
(-8.41%)
USD |
NASDAQ |
May 15, 16:00
5.83
+0.11
(+1.92%)
After-Hours: 20:00
REGENXBIO Total Liabilities (Quarterly) : 320.81M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.674B |
| Ocugen, Inc. | 51.10M |
| Replimune Group, Inc. | 123.05M |
| AbbVie, Inc. | 143.08B |
| Krystal Biotech, Inc. | 120.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 341.89M |
| Shareholders Equity (Quarterly) | 21.08M |
| Debt to Equity Ratio | 11.78 |
| Current Ratio | 2.623 |
| Net Debt Paydown Yield | -4.93% |